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Abstract
Background: Organisms that are sensitive to nitrofurantoin express a nitroreductase. Since
bacterial resistance to this compound results primarily from mutations in the gene encoding
nitroreductase, the resulting loss of function of nitroreductase results in a selectable phenotype;
resistance to nitrofurantoin. We exploited this direct selection for mutation to study the frequency
at which spontaneous mutations arise (transitions and transversions, insertions and deletions).
Results: A nitroreductase- encoding gene was identified in the N. gonorrhoeae FA1090 genome by
using a bioinformatic search with the deduced amino acid sequence derived from the Escherichia
coli  nitroreductase gene, nfsB. Cell extracts from N. gonorrhoeae were shown to possess
nitroreductase activity, and activity was shown to be the result of NfsB. Spontaneous
nitrofurantoin-resistant mutants arose at a frequency of ~3 × 10-6 - 8 × 10-8 among the various
strains tested. The nfsB sequence was amplified from various nitrofurantoin-resistant mutants, and
the nature of the mutations determined. Transition, transversion, insertion and deletion mutations
were all readily detectable with this reporter gene.
Conclusion: We found that nfsB is a useful reporter gene for measuring spontaneous mutation
frequencies. Furthermore, we found that mutations were more likely to arise in homopolymeric
runs rather than as base substitutions.
Background
Neisseria gonorrhoeae (GC) is an obligate human patho-
gen. In order to manifest the diversity of diseases that it is
able to cause, GC must produce a variety of cell surface
antigens such that the appropriate antigen(s) is (are)
expressed in the appropriate environment at the appropri-
ate time. Since each of the anatomical sites that GC can
infect has unique physiological properties, its success in
establishing itself in a new niche requires that it rapidly
adapt to its new environment. To do this, it has evolved a
variety of genetic mechanisms that result in high fre-
quency antigenic variation of its surface components.
These include: intramolecular recombination for pili anti-
genic variation [1]; changes in the number of pentameric
DNA repeat sequences for Opa expression [2]; and
changes in the length of a polyguanine tract for a variety
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of genes, including LOS variation [3,4], pilin glycosyla-
tion [5], pilC expression [6] and iron utilization [7,8]. Bio-
informatic analysis of the GC genome has identified a
variety of additional genes that may be subject to phase
variation that is mediated by some form of transient DNA
mispairing [9]. Since DNA mispairings, including inser-
tions and deletions, will arise as an intermediate in the
phase variation process, and the frequency of phase varia-
tion is so high, it suggests that this pathogen should be
defective in mismatch repair. However, studies in the
meningococcus indicate that this organism contains a
functional mismatch repair system [10], and homologs of
all of the identified genes are present in the FA1090
genome [11].
In addition to the presence of a mismatch repair system,
GC possesses homologs to genes that encode the proteins
for recombinational repair [12], very short patch repair
(DCS, unpublished observations), excision repair [13]
and oxidative damage repair [14]. This indicates that GC
is capable of dealing with most errors that might arise dur-
ing DNA metabolism. Previous studies on GC DNA repair
indicate that GC lacks error prone and photoreactivation
repair systems [15,16]. Homologs to genes associated
with error-prone repair and photoreactivation are not
present. For complete review of DNA repair capacities, see
review by Kline et. al. [11] or Ambur et. al. [17].
Nitroreductases have been identified in a wide variety of
microorganisms [18-22]. They were originally studied
because they are responsible for the reductive activation of
certain nitro-group containing antimicrobial agents (e.g.,
nitrofurantoin), generating highly reactive electrophilic
intermediates [23]. While the physiological role of
nitroreductases in bacteria is unknown, mutants lacking
nitroreductases are more resistant to nitroaromatic com-
pounds [24]. Since the loss of gene function is associated
with an increase in resistance to the antimicrobial agent,
we thought that these genes might provide an ideal start-
ing point for studying spontaneous mutation, as muta-
tions in these genes would not be biased by the
constraints of having to retain enzymatic function. We
used database searches to identify a potential nitroreduct-
ase in GC, cloned and expressed the gene, verified its bio-
chemical properties, and analyzed the DNA sequence of
the gene in spontaneous nitrofurnatoin-resistant mutants.
Methods
Bacterial strains and growth media
E. coli strain DH5α-mcr was used for genetic manipula-
tions and was obtained from Bethesda Research Laborato-
ries [now Life Technologies] (Rockville, MD). N.
gonorrhoeae  strains used in this study are described in
Table 1. N. gonorrhoeae were grown on GCK agar (GCMB,
Difco supplemented with 0.5% agar and Kellogg's supple-
ments) [25]. GCP broth was prepared by adding proteose
peptone #3 (15 g), soluble starch (1 g), KH2PO4 (4 g),
K2HPO4 (1 g), NaCl (5 g)/L of ultra-pure water (pH 7.5).
LB agar and broth were prepared from powder obtained
from US Biologicals. Plasmids used in this study are
described in Table 2.
Isolation of DNA
Chromosomal DNA for PCR reactions was prepared from
bacterial cultures by resuspending a small amount of cells
in 5:l 1 M NaOH. The solution was neutralized by adding
5:l of 0.5 M Tris-HCl (pH 7.5). The suspension was further
diluted in 90:l of purified water, and 1:l of this solution
was used as a template for PCR. Plasmid DNA isolations
were carried out according to the alkaline lysis procedure
[26].
Table 1: Bacterial strains used in these studies
Strain Relevant Phenotype Source
N. gonorrhoeae FA1090 P. Frederick Sparling
N. gonorrhoeae FA19 William Shafer
N. gonorrhoeae F62 P. Frederick Sparling
N. gonorrhoeae MS11 Herman Schneider
N. gonorrhoeae PID2 Herman Schneider
N. gonorrhoeae FA1090(M1) Spontaneous nitrofurantoin resistant mutant This Study
N. gonorrhoeae FA1090 -Nfsb(mod) Strain with a modified poly adenine tract in the beginning of the gene This Study
N. gonorrhoeae FA1090 NfsB-BsmI-Σ Strain lacking NfsB This StudyBMC Microbiology 2009, 9:239 http://www.biomedcentral.com/1471-2180/9/239
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PCR
Polymerase chain reactions (PCR) were performed using
various enzyme systems, based either on Taq or Pfu
polymerases using chromosomal or plasmid DNA as a
template. The primers used for various PCR reactions are
described in Table 3. Amplification conditions were gen-
erally 41 cycles, using an annealing temperature 5°C
lower than the Tm for the primer and extension times of
1-5 min. All PCR products were analyzed by agarose gel
electrophoresis.
DNA sequence analysis
DNA sequencing was performed by Macrogen, Inc.
(Seoul, Kr.) or the DNA sequencing facility at the Center
for Biosystems research at the University of Maryland. All
nfsB sequences were obtained using Primers S1 and S2.
Molecular biology procedures
All procedures were performed using methods described
in Sambrook et al. [27]. When biological reagents were
used, they were used under the conditions described by
their manufacturer. Restriction enzymes, T4 DNA ligase,
polynucleotide kinase and appropriate buffers were
obtained from New England Biolabs (Beverly, MA). S1
nuclease was obtained from Promega (Madison, WI).
DNA samples were analyzed on agarose gels (0.8-1.0%) in
TBE buffer [27].
Table 2: Plasmids used in these studies
Plasmids Properties Source
pK18 General cloning vector [38]
pHP45Σ Plasmid containing the Σ interposon [39]
pNFSB The nfsB region from FA1090 was amplified by PCR using primers NP1 and NP2. The amplicon was purified, digested with 
BamHI and cloned into the BamHI site in pK18.
This study
pEC1 The DNA between the adjacent BsmI sites were removed by digesting pEC2 with BsmI, ligating the DNA and 
transforming it into E. coli.
This study
pEC2 Two BsmI sites were inserted into pNFSB by PCR amplification using primers NfsBBsmI-3F and -2R, treating the amplicon 
with S1 nuclease and polynucleotide kinase, ligating the DNA and transforming it into E. coli.
This study
pEC3 A BsrGI site was introduced downstream of the NfsB coding sequence by PCR amplification of pEC1 using primers 
dwnstrm-F and dwnstrm-R. The amplicon was digested with BsrGI, ligated with a DNA fragment encoding the Σ 
interposon (amplified from pHP45Σ using Primer OmegaABC and digested with BsrGI) and transformed into E. coli.
This study
Table 3: Primers used in these studies
Primer Name Primer Sequence
NP1 AAAGGATCCCATGAACGCGGATTGCAGACG
NP2 GGGGGATCCAGAAGATACCATACGCCTCT
S1 GAGATGGGTAAAATCCGGGT
S2 CGAACCGGATGCCGTAGAA
dwnstrm-F AAAATGTACAATTTGCCGGGCGGCAGCCTGC
dwnstrm-R AAAATGTACAGGCGTTATCTCGCTCCCGGCG
Omega-ABC TCAGATGGCGCGCCTGTACATCGATGGTGATTGATTGACGAAGCTTTATGC
NfsB-BsmI-3F GTTTAGGGCGCATTCAAGAACCGCAAATCGTGCCGGC
NfsB-BsmI-2R GCGGTTCTTGAATGCGGATAGAACCTGCTCTTTGCTTAABMC Microbiology 2009, 9:239 http://www.biomedcentral.com/1471-2180/9/239
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Genetic procedures
Transformation-competent E. coli cells (strain DH5α-mcr)
were prepared using the procedure of Inuoe [28], and
stored at -80°C. To prepare cells for transformation, cells
were thawed on ice, DNA added and the mixture incu-
bated on ice for 10 min. The bacteria were heat-shocked at
37°C for 2 min., the total volume in the tube was
increased to 1 ml by adding LB broth and the transforma-
tion mixture incubated at 37°C for 30 min. to 1 hr. to
allow the bacteria to recover and begin expressing antibi-
otic-resistance proteins. Transformed bacteria were plated
onto LB agar plates containing appropriate antibiotics
and, if necessary, X-gal.
For transformation of N. gonorrhoeae, piliated bacteria
were resuspended to light turbidity in 1 ml GCK+ 10 mM
MgCl2 + Kellogg's supplement + 0.42% NaHCO3. DNA
was added to the culture, and the bacteria were incubated
at 37°C with shaking for 2-6 hours. Bacteria were plated
onto GCK agar plates containing the appropriate antibi-
otic, and the plates incubated for 36-48 hrs. When trans-
formations were performed under nonselective
conditions, a spot transformation procedure was used
[29]. For transformation, two piliated colonies were resus-
pended in 100:l GCP + 200 mM MgCl2 + 0.42% NaHCO3
+ Kellogg's supplement. The cell suspension was diluted
1:10, and additional two-fold serial dilutions were then
carried out 9 times. An aliquot (5:l) of each suspension
was spotted onto a GCK agar plate. To each spot, 5:l of
DNA were added. After incubation overnight at 37°C with
4% CO2, individual colonies were isolated and streaked
for isolation on GCK agar plates. The next day, individual
colonies were inoculated onto GCK and spectinomycin-
containing GCK agar plates. This procedure was repeated
until spectinomycin-sensitive colonies were obtained. The
correct replacement of the desired DNA fragment by the
transformation process was verified by PCR amplification
of the desired region, and restriction digestion analysis of
the PCR amplicon, or direct DNA sequencing of the PCR
amplicon.
Sequence modification of nfsB
The nfsB gene from strain FA1090 was amplified by PCR
using primers NP1 and NP2. The amplicon was purified,
digested with BamHI and cloned into the BamHI site in
pK18, resulting in plasmid pNFSB. To alter the poly ade-
nine sequence at the 5' end of the gene from AAAAA to
AAGAA, PCR primers NfsB-BsmI-F and NfsB-BsmI-R were
designed. The resulting amplicon was digested with BsmI,
ligated, and introduced into E. coli by transformation, giv-
ing pEC1. Plasmid pEC1 was amplified via PCR using the
primers dwnstrm-F and dwnstrm-R, allowing for the
insertion of a BsrGI site. A spectinomycin resistance cas-
sette was amplified from pMP45Σ using primer Omega-
ABC, and ligated into the BsrG1 site, resulting in pEC3.
This plasmid was used to transform strain FA1090 to spec-
tinomycin resistance, resulting in strain NfsB-BsmI-Ω. The
spectinomycin resistance cassette was removed using the
spot transformation procedure [29] with pEC1, producing
a strain that had an intact modified nfsB gene(FA1090-
NfsB(mod)). The correct construction was verified by
DNA sequence analysis of a PCR amplicon. The DNA
sequences for nfsB from the various strains have been sub-
mitted to GenBank with the following accession numbers:
F62, GU112780; MS11, GU112781; FA19, GU112782;
and PID2, GU112783. Point mutations in nfsB  that
resulted in nitrofurantoin resistance are identified in Gen-
Bank as accession numbers: GU112770; GU112771;
GU112772; GU112773; GU112774; GU112775;
GU112776; GU112777; GU112778; and GU112779.
MIC determinations
The minimum inhibitory concentration (MIC) of nitro-
furantoin for several gonococcal strains was determined
by a plate dilution method. Approximately 108 gonococci
were spotted onto media containing various amounts of
nitrofurantoin (1 μg/ml, 2 μg/ml, 3 μg/ml, 4 μg/ml, 6 μg/
ml, 8 μg/ml, 16 μg/ml and 32 μg/ml). The inoculated
plates were incubated overnight, and the MIC was defined
as the amount of nitrofurantoin needed in the plate to
completely inhibit the growth of the organisms in 24
hours.
Spontaneous mutation frequency determination
Cultures of GC were grown in GCP broth + 0.42%
NaHCO3 and Kellogg's supplement to exponential growth
phase, and aliquots (~1 × 108 cfu) plated onto GCK plates
containing 3:g/ml nitrofurantoin. Viable counts were
determined by plating cells onto GCK agar plates. Muta-
tion frequencies were defined as the number of colonies
obtained on nitrofurantoin-containing media divided by
the number of colonies obtained on GCK media.
Nitroreductase assay
Nitroreductase activity was measured by a modification of
the method of Whiteway et al. [24]. Cultures (100 ml) of
GC were grown in GCP broth + 0.42% NaHCO3 and Kel-
logg's supplement at 37°C with shaking to a turbidity of
100 klett units. Cells were collected by centrifugation
(~4,000 rpm for 10 min in a Sorvall GSA rotor), washed
with PBS, and resuspended in 5 ml 100 mM Tris-HCl, pH
7.5. Cells were lysed by sonication using a Branson soni-
cator with the microprobe, set on full power, using 5 10
sec pulses (Suspensions were incubated on ice for 1 min
between pulses). The sonicates were clarified by centrifu-
gation (~10,000 rpm for 30 min in a Sorvall SS-34 rotor)
and the supernatants collected. Protein concentrations of
each sample were measured with the BioRad protein assay
(Hercules, CA) using BSA as a standard, and samples were
normalized to the same protein concentration in 100 mM
Tris-HCl, pH 7.5. Samples containing 800:l lysate and 0.1
mM nitrofurazone were placed in a quartz cuvette, and theBMC Microbiology 2009, 9:239 http://www.biomedcentral.com/1471-2180/9/239
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reaction initiated by adding 100:l NADPH (2 mM stock).
A control reaction was performed using water instead of
nitrofurazone. Reactions were incubated at room temper-
ature and absorbance was measured every 30 sec at 400
nm.
Bioinformatics
A homolog of E. coli nfsB in the gonococcus was identified
by submitting the entire E. coli nfsB protein sequence to
http://blast.ncbi.nlm.nih.gov/Blast.cgi using the tblastn
program. The database option was set to "nucleotide col-
lection," and limited to Neisseria gonorrhoeae. The data-
base option was set to "bacteria," and the number of best-
scoring sequences to show was set to 250. The top scoring
hits from unique genera were aligned using ClustalW
http://www.ebi.ac.uk/Tools/clustalw/.
Results
MIC/Spontaneous Mutation Frequency Studies
If N. gonorrhoeae possesses a nitroreductase, it should be
sensitive to antimicrobial agents that are activated by
nitroreductases and it should be possible to isolate
mutants that become resistant to these activated antimi-
crobials due to the organism's loss of nitroreductase activ-
ity. We determined the MIC for nitrofurantoin, an
antimicrobial agent that is activated by nitroreductases,
for several different gonococcal strains. Plates were ana-
lyzed after 24 hrs incubation, and the concentration of
nitrofurantoin that completely inhibited the ability of GC
to form visible colonies was determined. The data indi-
cated that the MIC for nitrofurantoin was approximately
3:g/ml for all strains tested (data not shown). When plates
were incubated for an additional 24 hrs, a small number
of colonies arose, and these were presumptive nitrofuran-
toin-resistant mutants. By comparing the number of colo-
nies found on an agar plate after 48 hours incubation in
the presence of nitrofurantoin to the number of colonies
obtained when a similar aliquot was inoculated onto
media lacking the antimicrobial agent, we were able to
calculate the spontaneous mutation frequency to resist-
ance to this agent. The data (Fig. 1) indicate that the muta-
tion frequency associated with this antimicrobial agent
varied about 10 fold among strains, with FA1090 being
the least mutable among the strains tested, and MS11
being the most mutable. However, since it was possible to
isolate mutants that readily grew on media containing lev-
els of nitrofurantoin above the MIC, we hypothesized that
the mutation responsible for this phenotype was in the
coding sequence for the putative gonococcal nitroreduct-
ase gene.
Identification of potential nitroreductase genes
E. coli possesses two nitroreductases that can reduce these
nitro-aromatic compounds; nfsA and nfsB, plus a nitrore-
ductase activity encoded by a gene that has yet to be iden-
tified [18,24]. Therefore, it is possible that GC may
possess additional genes that confer nitroreductase activ-
ity. In E. coli, resistance to these nitro-aromatic antimicro-
bial agents occurs in a step-wise manner. A mutation that
knocks out the function of NfsA raises the MIC about
three fold. A second mutation that knocks out the func-
tion of NfsB increases resistance to about 10 times the
MIC of wild-type strains [18,24]. All attempts to isolate
second-step mutants in N. gonorrhoeae were unsuccessful,
indicating that this species only contains a single func-
tional nitroreductase, or that the additional nitroreduct-
ases were insensitive to nitrofurantoin.
Since two nitroreductases have been identified in E. coli,
nfsA and nfsB [30,31], we used the amino acid sequence
for these two gene products to search the gonococcal
translated genomic DNA sequence database. No signifi-
cant similarity was found to nfsA. However, an ORF
encoding a protein with some similarity to nfsB  was
found. This gonococcal sequence possessed 25% identity
and 44% similarity to the E. coli NfsB protein, suggesting
that this gene encoded a nitroreductase. The amino acid
sequence of the gonococcal homolog was used to probe
the GenBank database, and ORFs that possessed signifi-
cant similarity to it were identified. The data presented in
Figure 2 is an alignment of proteins that possessed signif-
icant similarity to the gonococcal nfsB homolog. All of
these proteins have nitroreductase activity.
Spontaneous mutation frequency of various lab strains of N.  gonorrhoeae Figure 1
Spontaneous mutation frequency of various lab 
strains of N. gonorrhoeae. Mutation frequencies were 
determined by counting the number of colonies arising on 
the GCK + Nitrofurantoin (3 μg/mL) plates after 48 hours of 
incubation at 37°C, 6% CO2, and dividing this number by the 
number of colonies arising on the GCK plates after 48 hours 
of incubation at 37°C, 6% CO2. Data represents experiments 
done in triplicate, with error bars representing standard 
error.
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DNA sequence analysis of nfsB from various gonococcal 
strains
The nfsB DNA sequence for N. gonorrhoeae strains F62,
FA19, MS11, and PID2 was determined by sequencing
PCR products amplified from their respective chromo-
somes. Sequence data were derived from multiple inde-
pendent amplicons. The data indicated that the DNA
sequence was highly conserved as all sequences obtained
were identical to the nfsB DNA sequence of FA1090, with
the exception of strain PID2. This strain possessed a single
nucleotide polymorphism (using the adenine of the start
codon as base one, at base 575 from the start codon, this
base is a guanine in FA1090 and a cytosine in PID2) that
would result in an amino acid substitution in NfsB at res-
idue 192 (a glycine in FA1090 and an alanine in PID2).
Since these proteins were essentially identical, it suggests
that the variability in spontaneous mutation frequencies
observed in these strains could reflect different DNA
repair capacities for the various strains.
Nitroreductase activity in N. gonorrhoeae
A spectrophotometric assay was performed to measure
nitroreductase activity in GC. Lysates from wild type and
nitrofurantoin resistant mutants were assayed for nitrore-
ductase activity using a spectrophotometric assay that
detects the loss of the substrate, nitrofurazone, using a
method adapted from Whiteway et al. [24]. The data (Fig.
3) show that we were able to detect nitroreductase activity
from strain FA1090, but that a spontaneous nitrofuran-
Sequence similarities of nitroreductases Figure 2
Sequence similarities of nitroreductases. The amino acid sequence encoding various nitroreductases were aligned. Iden-
tical residues are highlighted in black, and conserved substitutions are highlighted in grey. The sequences represent (Bacterium, 
Genebank identification number): Escherichia coli NP_415110.1, N. gonorrhoeae FA1090, NC002946; Haemophilus influenzae, 
Q57431; Bacillus subtilis; O34475; Helicobacter pylori, NP459570; and Agrobacterium tumefaciens str. C58, NP534964.BMC Microbiology 2009, 9:239 http://www.biomedcentral.com/1471-2180/9/239
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toin-resistant mutant (FA1090(M1)) lacked any detecta-
ble nitroreductase activity.
Genetic basis of nitrofurantoin resistance
In order to verify that the nitrofurantoin resistance
observed in the mutant was due to alterations in nfsB, the
DNA sequence of this region was determined from spon-
taneous nitrofurantoin resistant mutants by amplifying
the nfsB region from this strain. The data indicate that
FA1090(M1) possessed a small insertion of 7 nucleotides
about midway through the coding sequence, producing a
frame shift mutation in nfsB. This genetic data supported
the hypothesis that the nitrofurantoin resistant phenotype
is due to the loss of nitroreductase activity. Conclusive evi-
dence that this gene was responsible for nitrofurantoin
resistance was obtained by deleting the coding sequence
for this gene from FA1090 and then demonstrating that
FA1090NfsB-BsmIS lacked nitroreductase activity (data
not shown).
Identification of the genetic basis of spontaneous 
nitrofurantoin resistant mutants
We isolated numerous independent spontaneous nitro-
furantoin resistant mutants and determined the DNA
sequence of the nfsB gene in these strains. Most of these
mutants (90%) possessed the insertion of an adenine in a
run of 5 adenines near the beginning of the gene, suggest-
ing a bias for base insertion during DNA replication at this
position. This gene contains three other polynucleotide
runs of five nucleotides distal to the start codon; 2 poly
adenines and one polythymine. Interestingly, even
though we were able to isolate base insertions at each of
these three clusters, none of the clusters showed the ele-
vated propensity for generating spontaneous mutations.
To eliminate the bias introduced by the 5 bp polyadenine
run at the 5' end of the gene, this DNA sequence was
altered to remove the poly-A tract, while preserving the
corresponding amino acid sequence. The plasmid, pEC3
was constructed as described in figure 4. Plasmid DNA
was isolated from E. coli and DNA used to transform N.
gonorrhoeae. Spectinomycin resistant transformants were
identified, and DNA sequence analysis of a PCR amplicon
derived from the constructed strain indicated that the
derivative of FA1090, FA1090-NfsB(mod) contained the
desired sequence modification. Nitroreductase assays of
this strain indicated that it possessed wild-type NfsB activ-
ity (data not shown).
We isolated spontaneous nitrofurantoin resistant mutants
of strain FA1090-NfsB(Mod), by plating this strain on
GCK agar containing 3:g/ml nitrofurantoin. We deter-
mined the genetic basis of 107 individual independently
isolated mutants that arose from this plating by amplify-
ing the desired region using Primers NP1 and NP2, and
determining the DNA sequence of nfsB using Primers S1
and S2. The experimental design employed should allow
for the identification of six different types of mutations,
four that would be manifested within the coding sequence
of nfsB (missense mutations, nonsense mutations, inser-
tions, deletions) and mutations outside of the coding
sequence, presumably mutations that effected nitrofuran-
toin uptake, or in the regulation of nfsB expression. The
data presented in Table 4 summarizes the types of muta-
tions identified by our DNA sequence analysis of PCR
amplicons. The data indicate that about half of the
mutants possessed point mutations, one quarter pos-
sessed insertions and one quarter possessed deletions. The
largest insertion mutant was 7 bp in length and the largest
deletion was 5 bp in length. None of the multiple base
insertions appeared to be the result of duplications in the
native coding sequence and none of the deletions
appeared to eliminate repeated sequences or sequences
that contained obvious secondary structure. Furthermore,
insertions did not seem to show a preference for expand-
ing short (4 bp) polynucleotide runs, but seemed to ran-
domly incorporate one or more nucleotides.
Use of nonsense mutations to characterize transition and 
transversion rates
Any point mutation that is capable of generating a stop
codon could generate a cell that is resistant to the killing
action of nitrofurantoin. Visual analysis of the coding
sequence for nfsB identified 23 possible bases where a sin-
gle base change would result in the production of a stop
Nitroreductase activity in N. gonorrhoeae strains Figure 3
Nitroreductase activity in N. gonorrhoeae strains. Cell 
sonicates were tested for their ability to produce a loss of 
absorbance at 400 nm, indicating a reduction of nitrofura-
zone by an active nitroreductase. The symbols represent: 
FA1090 (); FA1090 extract lacking NADPH (); and 
FA1090(M1), an nfsB mutant of FA1090 (). Samples meas-
ured every 30 sec for 10 min. The data represents the aver-
age of 7 separate experiments with the error bars 
representing the standard error.
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codon. We identified 33 mutations that resulted from this
type of base change. The distribution of the mutations
obtained suggested that no hot spot for mutation existed
in any of these sequences (see Table 4). We obtained a
total of 27 transition mutations and 26 transversion
mutations, suggesting that no preference exists for gener-
ating these types of mutations. Interestingly, the number
of deletion and insertion mutations occurred at approxi-
mately the same frequency as the number of transition
and transversions.
Analysis of mutations
While the majority of the collected mutations were inser-
tion, deletion or nonsense mutations, we did identify a
variety of key residues in the NfsB protein that are essen-
tial for its function. The data in Figure 5 indicate key resi-
dues, that when mutated, resulted in the loss of sensitivity
to nitrofurantoin. While we did not perform biochemical
analysis on the nitroreductase of all of these mutants, of
those tested, we detected no activity, suggesting that these
mutations reside in key residues.
Discussion
Phase variation is a reversible, high-frequency phenotypic
switching that is mediated by changes in the DNA
sequence that effects the expression of the target gene. The
ability of individual genes to phase vary contributes to
population diversity and is important in niche adapta-
Schematic illustrating the strategy used to modify the nfsB coding region Figure 4
Schematic illustrating the strategy used to modify the nfsB coding region. Each numbered arrow corresponds to the 
procedures summarized below: 1: PCR using primers NfsBsmI-3F and NfsBsmI-2R to introduce a BsmI recognition sequence 
and to alter a poly-A tract. 2: Treatment with S1 nuclease to create blunt ends, polynucleotide kinase to phosphorylate 5' ends, 
and T4 DNA ligase. E. coli were transformed using this construct (pEC2). Plasmid DNA was isolated by alkaline lysis. 3: Treat-
ment with BsmI to generate pEC1. Digestion product was ligated with T4 DNA ligase. The construct was transformed into E. 
coli. 4: pEC1 was amplified with primers dwnstrm-F and dwnstrm-R. The product was ligated to the omega fragment, a PCR 
product of pHP45Σ with the OmegaABC primer, to generate pEC3. The omega fragment is symmetric, so one primer amplifies 
in both directionsBMC Microbiology 2009, 9:239 http://www.biomedcentral.com/1471-2180/9/239
Page 9 of 11
(page number not for citation purposes)
tion. Understanding which genes are capable of undergo-
ing phase variation is the first step defining which genes
are important in disease pathogenesis. Being able to deter-
mine the rate at which these processes occur and the
nature of any factors that influence them is integral to
understanding the impact of these processes on the evolu-
tion and dynamics of the population as a whole and on
the host-bacterium interaction. Studies on phase variation
in the gonococcus have been hampered by our lack of
knowledge of background mutation frequencies.
We reasoned that analysis of genes, whose loss of function
would provide for a positive selection, would allow for an
unbiased comparative analysis of spontaneous mutations,
and the study of spontaneous mutation in these genes
would provide baseline information for future studies on
factors that might effect antigenic variation. We further
reasoned that with this knowledge, we could distinguish
between changes in gene expression that were the result of
slip strand mispairing during DNA replication from
changes due to other forms of mistakes that occur during
DNA replication.
We determined that N. gonorrhoeae encodes a nitroreduct-
ase gene (nfsB). The inability to isolate second-step nitro-
furantoin resistant mutants suggested that the gonococcus
only contained a single nitroreductase. We obtained bio-
chemical data to support this conclusion, where mutants
that were resistant to nitrofurantoin lost the ability to
reduce nitrofurantoin. Since cell lysates that did not con-
tain the co-factor NADPH had no nitroreductase activity,
it indicated an absolute requirement for this co-factor.
However, we did not determine if other molecules such as
NADH could substitute for the NADPH requirement, or if
the organism might have other nitroreductases that uti-
lized a cofactor other than NADPH.
Table 4: Analysis of mutations resulting in nitrofurantoin resistance
Point mutationsa Frameshift mutation
Nonsense Missense Insertions (single site) Deletions (single site)
CAA->TAA 7 Transitions Single base 22 Single base 16
CAG->TAG 11 C->T 5 Multiple bases 4 Multiple bases 9
TCG->TAG 9 T->C 2
GAG->TAG 5 A->G 0
TGG->TGA 1 G->A 1
Transversions Mutations in promoter region 3
T->A 3
A->T 0
G->C 1
C->G 1
T->G 5
G->T 0
A->C 0
C->A 2
Total: 33 20 26 25 3
aOf the 53 point mutations examined, 27 were transitions and 26 were transversions.BMC Microbiology 2009, 9:239 http://www.biomedcentral.com/1471-2180/9/239
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We determined the nature of spontaneous mutation by
analyzing where mutations occurred in nfsB. While we
were able to identify mutations that would result in
amino acid substitutions in the region involved in FMN
binding [24], the majority of the mutations were outside
of this region, with most of them clustering in the amino
terminus of the protein. This was somewhat surprising,
given that this region of the protein is not well conserved
in known nitroreductases.
The results of the spontaneous mutation frequency plat-
ing experiments and the subsequent genetic analysis
showed that nitrofurantoin resistance is a potential target
for analyzing mutation in the gonococcus. The fact that
almost all mutations originally examined resulted in an
extension of a polyadenine run of 5 adenines was surpris-
ing, as it is thought that this sequence is too short to par-
ticipate in strand slippage. Furthermore, the absence of
slippage at two other polyadenine runs of 5 in other loca-
tions indicates that sequence context is important in
strand slippage.
The use of nfsB as a reporter system allowed us to assess
the nature of spontaneous mutation in an unbiased fash-
ion. If one removes the high frequency of errors that
occurred in the polynucleotide run of adenines, the pro-
pensity of errors directed towards transitions and transver-
sions occurred at a similar frequency to insertion or
deletion mutations. However, the high rate of insertions
and deletions is in contrast to what was observed by
Schaaper and Dunn [32], who in their studies of sponta-
neous mutation in the lacI gene of Escherichia coli saw that
single base insertions and deletions only made up 4.2% of
their observed mutations. While we observed that single
base insertions and deletions accounted for ~40% of our
observed mutations in a background where a run of five
adenines was removed, if the bias observed at this
sequence was included, insertions would have made up
about 75% of all observed mutations. The implication of
this finding would suggest that homopolymeric runs
should have a tendency to increase, and that they should
dominate the types of mutations seen in the gonococcus.
This is precisely what is observed. The mechanism by
which gonococcal DNA polymerase allows this to occur,
and the inability of the gonococcus to efficiently correct
insertions indicates that gonococcal DNA repair is some-
what different from that seen in E. coli.
Most of our understanding of DNA repair in the Neisseria
has come from studies focused on understanding the con-
tribution of various DNA repair proteins in preventing
mutations in rpoB in the gonococcus or meningococcus.
These studies have analyzed numerous strains for the rate
of spontaneous resistance to rifampicin, and find that in
general, this rate is between ~1 × 10-8 - 1 × 10-9 [33-36].
Our data indicate that mutants resistant to nitrofurantoin
arose at a much higher frequency (~3 × 10-6 - 8 × 10-8). We
believe that the higher mutation frequencies that we
observed relate to the nature of the selection procedure
employed. Mutation screens designed to detect rpoB
mutants are constrained in that they must result in the
production of a functional protein. Our screening proce-
dure allowed us to detect any mutation that results in the
loss of function of the target, and hence is able to identify
insertions and deletions, as well as point mutations. We
believe that the elevated mutation frequency that we
observed for nfsB, relative to that observed by others for
rpoB was due to the presence of the polyadenine sequence
in nfsB and our ability to detect frame shift mutations.
Race and coworkers [37] have solved the crystal structure
of NfsB isolated from E. coli. Interestingly, none of the
mutations that we identified were contained in any of the
key residues that they demonstrated to be interacting with
nitrofurantoin. However, a significant number of the
amino acid substitutions that we identified would be
expected to have dramatic structural implications.
Conclusion
In summary, we found that nfsB is a useful reporter for
measuring spontaneous mutation frequencies. Its ability
to detect elevated mutation frequencies in very short poly-
nucleotide runs indicates that any gene that contains a
short polynucleotide run has the potential to phase vary.
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